CAS: 42860-04-8; 4-Chloro-3-Iodobenzoic Acid

该化合物是一种芳香的碳酸,其特点是苯环上含有氯和碘替代物,具体地说,氯原子位于与碳苯酸组相对的副位置(4个位置),碘原子位于与碳苯酸组相对的元位置(3个位置),该化合物一般是白色到白色的固体,在水中溶解,但更易溶于乙醇和丙酮等有机溶剂,分子结构有助于其再活动,使其在各种化学合成物中有用,特别是在制药和农用化学物的开发中.卤素的存在会影响化合物的电子特性,影响其酸性和在替代电药用反应中的再活性.此外,4-Crololoo-3-iodobenzoic酸可能展示生物活动,可在医药化学环境中加以探讨.在处理这一化合物时,应采取安全防范措施,因为如果是吸入或吸入,可能会对健康造成危害.

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号74-11-3 对氯苯甲酸 | CAS号2840-28-0 3-氨基-4-氯苯甲酸 | CAS号276866-90-1 3-碘-4-氯苯甲醛 | CAS号16588-34-4 4-氯-3-硝基苯甲醛 | CAS号1018687-71-2 4-chloro-3-(2-h... | CAS号104317-95-5 4-氯-3-碘苄醇 | CAS号710350-72-4 4-氯-3-(4,4,5,5-... | CAS号834895-42-0 1-[2-iodo-4-(3-... | CAS号834895-49-7 (4-chloro-3-iod... | CAS号834895-51-1 (3-iodo-4-pyrro... | CAS号42860-17-3 4-氯-3-碘苯甲酰氯

合成工艺路线路线简述

  • 合成目标产物 4-Chloro-3-Iodobenzoic Acid 主要起始原料 4-Chloro-3-Nitrobenzaldehyde
  • (文献来源)合成步骤主要原料 4-Chloro-3-Nitrobenzaldehyde
📜对氯苯甲酸置于sodium Periodate,硫酸,Potassium Iodide体系中,化学反应 1.0H,以84%的收率获得产物4-氯-3-碘苯甲酸
参考文献:I2/naio4 和 Ki/naio4 碘化体系对浓硫酸中失活芳烃的氧化碘化
标题:I2/naio4 和 Ki/naio4 碘化体系对浓硫酸中失活芳烃的氧化碘化
摘要:用强亲电 I + 试剂对失活的芳烃进行单碘化或二碘化,这些试剂由 Naio 4 和 I 2 或 Ki 在浓 H 2 So 4 中制备(至少 95% 重量).通常使用稍微过量的深棕色碘化溶液(1.1/1.5 当量,对于硝基苯需要两个当量).碘化在 25-30 oc 下进行,反应时间为 1-2 小时,使用芳香族碘化的"直接"或"反向"方法以 31-91% 的优化产率得到单碘化或二碘化纯产物.
DOI:10.1055/s-2006-926374

海关参考信息

专利信息


专利号:US-2009076268-A1
优先权日:2007-09-14
标 题:Facile assembly of fused benzofuro-heterocycles
发明人:FITZGERALD ANNE E; LIU JING; MANI NEELAKANDHA S
权利人:FITZGERALD ANNE E; LIU JING; MANI NEELAKANDHA S
摘要:This invention concerns the synthesis of polycyclic structural components of pharmacological compounds, including the synthesis of fused benzofuro-heterocycles, through selective palladium-catalyzed cross-coupling and intramolecular cyclization.

专利号:US-10226449-B2
优先权日:2013-12-20
标 题:Heterocyclic modulators of lipid synthesis and combinations thereof
发明人:HEUER TIMOTHY SEAN; OSLOB JOHAN D; MCDOWELL ROBERT S; JOHNSON RUSSELL; YANG HANBIAO; EVANCHIK MARC; ZAHARIA CRISTIANA A; CAI HAIYING; HU LILY W; DUKE GREGORY; OHOL-GUPTA YAMINI; O'FARRELL MARIE
权利人:3 V BIOSCIENCES INC
摘要:Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by dysregulation of a fatty acid synthase pathway by the administration of such compounds and combinations of such compounds and other therapeutic agents.

专利号:US-9428502-B2
优先权日:2012-07-03
标题:Heterocyclic modulators of lipid synthesis
发明人:OSLOB JOHAN D; MCDOWELL ROBERT S; JOHNSON RUSSELL; YANG HANBIAO; EVANCHIK MARC; ZAHARIA CRISTIANA A; CAI HAIYING; HU LILY W; WAGMAN ALLAN S
权利人:3-V BIOSCIENCES INC
摘要:Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds.

专利号:US-2018222892-A1
优先权日:2012-07-03
标 题 :Heterocyclic modulators of lipid synthesis

专利号:EP-3083583-B1
优先权日:2013-12-20
标 题:Heterocyclic modulators of lipid synthesis and combinations thereof

专利号:CA-2934251-A1
优先权日:2013-12-20
标题:A combination of heterocyclic modulators of lipid synthesis and chemotherapeutic drugs in treatment of cancer

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Li, Y.; Fang, X.; Wang, Y., Science of Synthesis: DNA-Encoded Libraries, (2024) nan, 24.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知